America's FDA Approves First 'Female Viagra'
The Food and Drug Administration has approved a new drug designed to increase sexual desire for women, according to the Associated Press.
Addyi is a non-hormonal pill taken once a day, and unlike Viagra, targets the brain instead of genital organs. It is designed to treat hypoactive sexual desire disorder (HSDD) in premenopausal women, which is a "persistent absence of sexual thoughts, fantasies, responsiveness, and willingness to engage in sexual activity."
It is the first and only FDA-approved treatment for this condition, which is the most common form of female sexual dysfunction (1 in 10 women in the United States are affected by it). Like any drug, Addyi comes with safety restrictions, including dangers of taking it with alcohol and other medications like those used to treat yeast infections.
As for when women will be able to get their hands on Addyi, it could be on the market as early as October 17.